Want to sleep better? You’re not alone!
Insomnia and poor sleep are very common societal complaints and can be present in individuals with and without sleep-related
disorders. It is well known that poor sleep is a symptom of both psychiatric as well as general medical illnesses. Impaired sleep has
broad effects on worsening physical and psychological symptoms, and it contributes to increased morbidity and mortality of numerous
diseases. This is in addition to reduced social functioning, economic productivity, and overall lower quality of life.
Historically, multiple treatments have been employed to combat insomnia related concerns. These often involve pharmacotherapy
with sedatives and hypnotics that, while useful for a subset of the population, can be either insufficient, ineffective or bring with them
concerning adverse effects.
CBTi is increasingly being recognized as the recommended treatment modality for primary insomnia, and is also gaining traction as
benefitting other conditions where sleep is a concern. Beyond its success for targeting insomnia, its value is bolstered by the
incorporation of long-lasting psychotherapeutic elements. Furthermore, less polypharmacy and reduced medication dependence are
In 2018, a new program offering group CBTi began at the University of Alberta Hospital’s Psychiatry Department. This is a joint effort
between Psychology and Psychiatry, which is expanding on the already established one-on-one CBTi treatment available.
This presentation is intended to summarize CBTi as a treatment, introduce the structure of the Group CBTi program, and review early
qualitative and quantitative data.